Evidence map›Paper›PMID 32336981›Full record

ArticleInfectious agents and cancer2020

Systematic screening for cervical cancer in Dakar region: prevalence and correlation with biological and socio-demographic parameters.

Dominique Diouf, Gora Diop, Cheikh Ahmadou Tidian Diarra, Aminata Issa Ngom, Khadija Niane, Moussa Ndiaye, Sidy Ka, Oumar Faye, Ahmadou Dem

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Dominique Diouf1Laboratory of cytogenetic and reproductive biology, Hopital Aristide-Le-Dantec, Pasteur Avenue, PO Box 3001, Dakar, Senegal.
Gora DiopCancer Studies and Research Group in Senegal (GERCS), Cheikh Anta Diop Avenue, PO 5005, Dakar, Senegal.
Cheikh Ahmadou Tidian DiarraInstitut-Juliot-Curie, Hospital Aristide Le Dantec, Pasteur Avenue, PO Box 3001, Dakar, Senegal.
Aminata Issa Ngom1Laboratory of cytogenetic and reproductive biology, Hopital Aristide-Le-Dantec, Pasteur Avenue, PO Box 3001, Dakar, Senegal.
Khadija Niane6Immunology & Biology of infectious diseases Unit, Institut Pasteur Dakar, 36, avenue Pasteur, PO Box 220, Dakar, Senegal.
Moussa Ndiaye6Immunology & Biology of infectious diseases Unit, Institut Pasteur Dakar, 36, avenue Pasteur, PO Box 220, Dakar, Senegal.
Sidy KaInstitut-Juliot-Curie, Hospital Aristide Le Dantec, Pasteur Avenue, PO Box 3001, Dakar, Senegal.
Oumar Faye1Laboratory of cytogenetic and reproductive biology, Hopital Aristide-Le-Dantec, Pasteur Avenue, PO Box 3001, Dakar, Senegal.
Ahmadou DemInstitut-Juliot-Curie, Hospital Aristide Le Dantec, Pasteur Avenue, PO Box 3001, Dakar, Senegal.
Cheikh Anta Diop University · SNHôpital Aristide Le Dantec · SNInstitut Pasteur de Dakar · SN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer is a major public health problem. In 2018, globally 569,847 cervical cancer were diagnosed and 311,000 deaths were projected due to this preventable disease. Worldwide, therefore, the cervical cancer disease ranks as the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women in 2018.The high rate of dysplasia in Senegal and the absence of well-organized screening programs informed this study, which aims to determine the prevalence of cervical dysplasia and its relationship to biological and socio-demographic characteristics.

methodsThis study is based on 1000 conventional smears collected during routine cervical cancer screening at the Gaspard Camara Health Center and the Histology - Embryology and Cytogenetics Laboratory of the Cheikh Anta DIOP University in Dakar. The smears were read according to the Bethesda and Richart systems. However, all data were returned to the Bethesda system using the correspondence table between the different classifications of squamous cell lesions of the cervix. Some of the patients with abnormal smears had colposcopy and if necessary a biopsy. Other patients with low-grade lesions were recommended to have their smears resumed in 6 months or 1 year later.

resultsCytological analysis was performed for 1000 patients aged 16 to 82 years (mean age = 41 ± 11.16). Among these, 176 patients had abnormal smears, 23 had Atypical Squamous Cells of Undetermined Significance (ASCUS), 143 had a low-grade lesion, 9 had a high-grade lesion and 1 had carcinoma. Among the remaining 822 patients, cytological analysis revealed no suspected malignant lesions, but 623 among them had dystrophy and 2 were unsatisfactory. Among patients with abnormal smears, 104 patients (23 ASCUS + 71 low grade + 9 high grade + 1 carcinoma) had performed colposcopy, 40 of whom had normal colposcopy and 64 had abnormalities. Sixty-four (64) biopsies were performed. Four (4) were not satisfactory. However, for 26/60 biopsies, the histology was normal, 21/60 had a low grade, 11 displayed a high grade and only 2 had carcinoma. Among the 176 patients with abnormal smears, 72 low-grade patients had undergone cytological examination 6 months to 1 year later to determine the persistence, regression or progression of low-grade dysplasia. During follow-up, persistence was observed in 25% (

conclusionIn this study, the prevalence of abnormal smear was 17.60% for cytology. Meanwhile, the Colposcopy and histology confirmed just 3.40%. These results underline the interest and need for a review of the discrepancies observed between pathologists.

Indexed as

Cervical cancerDysplasiaEpidemiologyPrevalenceSenegal

Identifiers

PMID32336981
PMCPMC7178929
OpenAlexW3018879940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.